| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.14 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.6 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.072 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |